Population pharmacokinetics and exposure‐response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis

Documenti analoghi

• Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
  di: Sumit Bhatnagar, et al.
  Pubblicazione: (2024)
• Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors
  di: Guihong Yang, et al.
  Pubblicazione: (2024)
• Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development
  di: Ana Victoria Ponce‐Bobadilla, et al.
  Pubblicazione: (2024)
• Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
  di: Thanakorn Surarak, et al.
  Pubblicazione: (2024)
• Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplant
  di: Yuki Suzuki, et al.
  Pubblicazione: (2024)